Enikő R. Tőke

Dr. Tőke has broad interdisciplinary experience of more than 20 years in translational research with special focus on preclinical/clinical immunotherapy development (on the field of HIV/AIDS, allergy and cancer). Previously, her research team developed Langerhans cell-targeting immunotherapies, nanomedicine delivery systems, pharmaceutically acceptable polymer syntheses (“novel excipient”) and medical device. All of these were applied in clinical drug development. Additionally, she has strong knowledge of FDA regulations, ICH guidelines GMP manufacturing and quality system establishment. Dr. Tőke is a graduate of Budapest University of Technology and Economics, Budapest, Hungary (PhD) and of Babes-Bolyai University, Faculty of Biochemical Engineering, Cluj-Napoca, Romania (MSc).